Trial Profile
Pharmacokinetic Parameters of Fimasartan in Russian Patients with Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension
- 03 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.